Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion
OTCMKTS:CURLF

Curaleaf 2/26/2026 Earnings Report

Curaleaf logo
$3.46 0.00 (0.00%)
As of 05/18/2026 03:59 PM Eastern

Curaleaf EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.08
Beat/Miss
Beat by +$0.03
One Year Ago EPS
N/A

Curaleaf Revenue Results

Actual Revenue
$333.07 million
Expected Revenue
$328.70 million
Beat/Miss
Beat by +$4.37 million
YoY Revenue Growth
N/A

Curaleaf Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Curaleaf Earnings Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates. The company also offers proprietary CBD wellness products designed to address pain relief, stress management and sleep support. Curaleaf’s dispensaries provide personalized consultation services, allowing both medical patients and adult-use consumers to select products best suited to their needs. In addition, Curaleaf supplies wholesale products to other licensed retailers in states where it holds cultivation and processing licenses.

Founded in 2010, Curaleaf has expanded through strategic acquisitions, including the 2019 purchase of Grassroots Cannabis and the 2020 acquisition of Select, a premium U.S. cannabis oil brand. These transactions have broadened the company’s geographic footprint and product capabilities. Under the leadership of CEO Matt Darin, Curaleaf continues to pursue disciplined growth, regulatory compliance and innovation in cannabinoid research to support its long-term vision of becoming the most trusted brand in global cannabis.

View Curaleaf Profile